Ognyan Donev, CEO Sopharma

CEO Ognyan Donev ups his stake in Sopharma

CEO Ognyan Donev controlled key shareholder in Sopharma (3JR BU) ups his stake in the company, according to a regulatory filing. Donev Investments Holding has acquired 503 000 shares or 0.37% of the share capital, according to the filing. Post the transaction Donev Investments Holding’s stake has increased to 25.15%. Sopharma’s key holding structure acquires… Read more